138 related articles for article (PubMed ID: 14556791)
21. N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues.
Wei ZY; Brown W; Takasaki B; Plobeck N; Delorme D; Zhou F; Yang H; Jones P; Gawell L; Gagnon H; Schmidt R; Yue SY; Walpole C; Payza K; St-Onge S; Labarre M; Godbout C; Jakob A; Butterworth J; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
J Med Chem; 2000 Oct; 43(21):3895-905. PubMed ID: 11052794
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and pharmacological evaluation of bicyclic SNC80 analogues with separated benzhydryl moiety.
Jung B; Englberger W; Fröhlich R; Schepmann D; Lehmkuhl K; Wünsch B
Bioorg Med Chem; 2008 Mar; 16(6):2870-85. PubMed ID: 18249546
[TBL] [Abstract][Full Text] [Related]
23. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
[TBL] [Abstract][Full Text] [Related]
24. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
[TBL] [Abstract][Full Text] [Related]
25. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
[TBL] [Abstract][Full Text] [Related]
26. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
[TBL] [Abstract][Full Text] [Related]
27. Opioid receptor characterisation of neuronally stimulated isolated human vas deferens.
Root J; Wakenhut AM; Siggins H; Katugampola S; Napier C
Naunyn Schmiedebergs Arch Pharmacol; 2012 Nov; 385(11):1049-52. PubMed ID: 22752269
[TBL] [Abstract][Full Text] [Related]
28. Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes.
Derouiche L; Pierre F; Doridot S; Ory S; Massotte D
Molecules; 2020 Sep; 25(19):. PubMed ID: 33007971
[TBL] [Abstract][Full Text] [Related]
29. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
[TBL] [Abstract][Full Text] [Related]
30. Opioid modulation of ferret vagal afferent mechanosensitivity.
Page AJ; O'Donnell TA; Blackshaw LA
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G963-70. PubMed ID: 18258789
[TBL] [Abstract][Full Text] [Related]
31. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
32. Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.
Banks ML; Roma PG; Folk JE; Rice KC; Negus SS
Psychopharmacology (Berl); 2011 Aug; 216(3):431-9. PubMed ID: 21369752
[TBL] [Abstract][Full Text] [Related]
33. Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins.
Lecoq I; Marie N; Jauzac P; Allouche S
J Pharmacol Exp Ther; 2004 Aug; 310(2):666-77. PubMed ID: 15102931
[TBL] [Abstract][Full Text] [Related]
34. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
[TBL] [Abstract][Full Text] [Related]
35. (+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor.
Thomas JB; Herault XM; Rothman RB; Burgess JP; Mascarella SW; Xu H; Horel RB; Dersch CM; Carroll FI
Bioorg Med Chem Lett; 1999 Oct; 9(20):3053-6. PubMed ID: 10571174
[TBL] [Abstract][Full Text] [Related]
36. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
37. Novel diazabicycloalkane delta opioid agonists.
Loriga G; Lazzari P; Manca I; Ruiu S; Falzoi M; Murineddu G; Bottazzi ME; Pinna G; Pinna GA
Bioorg Med Chem; 2015 Sep; 23(17):5527-38. PubMed ID: 26252963
[TBL] [Abstract][Full Text] [Related]
38. Stereospecific synthesis of (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide.
Lu Y; Weltrowska G; Lemieux C; Chung NN; Schiller PW
Bioorg Med Chem Lett; 2001 Feb; 11(3):323-5. PubMed ID: 11212101
[TBL] [Abstract][Full Text] [Related]
39. Binding of [3H](+)-BW373U86 to delta-opioid receptors in rat brain membranes.
Campa MJ; McNutt RW; Hill JA; Patz EF; Chang KJ
Eur J Pharmacol; 1996 Aug; 310(2-3):263-7. PubMed ID: 8884225
[TBL] [Abstract][Full Text] [Related]
40. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
